Remove 2018 Remove Diagnose Remove Diagnosis Remove Medical
article thumbnail

Effects of the COVID-19 pandemic on primary care for diabetes in Canada: Results from a mixed-methods study [Health care services, delivery, and financing]

Annals of Family Medicine

Setting & Dataset: The CPCSSN database contains de-identified patient-level electronic medical record data from 13 primary care research networks across Canada. Population Studied: Using CPCSSN data, we defined a cohort of patients aged 50-105 with diabetes diagnosed before the pre-pandemic period.

article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

However, things are moving fast, and success doesn’t come easy for the pioneers of any medical field. Their research showed promising results for lab rats, and they plan to carry out the first human trials in the second half of 2017 and gather preliminary results during 2018.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Working Out – Dan Minter

The Clinical Problem Solvers

If you’re anything like me, you’ve probably found yourself asking that question after listening to a discussant on the podcast arrive at some unexpected diagnosis, only to have the biopsy or lab test prove them right. Dr.’s Vivek Murthy, Bridget O’Brien, and Gurpreet Dhaliwal sought to answer this question in a 2018 study.

article thumbnail

How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin

GeriPal

We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. So, the question becomes, what, if anything, should we do differently in the primary care setting to diagnose the disease? How should we screen for cognitive impairment? Does a good history matter anymore?

article thumbnail

Time to stop driving? Podcast with Emmy Betz and Terri Cassidy

GeriPal

Eric: For those of you don’t know, Emmy was on our podcast back in 2018 … man, pre-COVID times. Often when there’s a cognitive concern, it’s a family member that is calling saying, “I just want to make sure my mom should still be driving after this happened, or after this diagnosis.”

Family 102
article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

There is a lot to digest with these draft clinical guidelines but the big change from the 2018 guideline is moving Alzheimers to a biological diagnosis (biomarker evidence only) not just for a research framework but now from a clinical one. And we’ve been diagnosing it at Penn. Welcome back to GeriPal podcast, Sharon.

article thumbnail

Pragmatic Trial of ACP: Jennifer Wolff, Sydney Dy, Danny Scerpella, and Jasmine Santoyo-Olsson

GeriPal

But most people with dementia are initially diagnosed and medically managed in primary care, and they really desire clinicians to initiate these conversations but there are a number of really important barriers for these conversations taking place. Why did you even bother doing this study? Jennifer 04:34 Yeah, thanks for the question.